Beverly Hills, CA13 Active Studies

Interstitial Cystitis Clinical Trials in Beverly Hills, CA

Find 13 actively recruiting interstitial cystitis clinical trials in Beverly Hills, CA. Connect with local research sites and explore new treatment options.

13
Active Trials
12
Sponsors
12,793
Enrolling

Recruiting Interstitial Cystitis Studies in Beverly Hills

RecruitingBeverly Hills, CANCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and ca...

5,000 participants
AstraZeneca
View Study Details
RecruitingBeverly Hills, CANCT06268873

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This study consists of a screening, a 4-week dapagliflo...

2,500 participants
AstraZeneca
View Study Details
RecruitingBeverly Hills, CANCT07001800

A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults....

1,410 participants
Kardigan, Inc.
View Study Details
RecruitingBeverly Hills, CANCT04108156

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibi...

634 participants
Hoffmann-La Roche
View Study Details
RecruitingBeverly Hills, CANCT06510816

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration (AMD)....

630 participants
Annexon, Inc.
View Study Details
RecruitingBeverly Hills, CANCT06337318

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a p...

600 participants
National Cancer Institute (NCI)
View Study Details
RecruitingBeverly Hills, CANCT04895241

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active...

540 participants
Biogen
View Study Details
RecruitingBeverly Hills, CANCT05646381

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

The purpose of this study is to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) administered subcutaneously once monthly compared to placebo in slowing the progression of calcifi...

502 participants
Novartis Pharmaceuticals
View Study Details
RecruitingBeverly Hills, CANCT05949593

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

This Phase 3, multicenter, double-masked, parallel-group, placebo-controlled, randomized, fixed-dose clinical study is designed to evaluate the efficacy and safety of tinlarebant (LBS-008) in subjects...

429 participants
Belite Bio, Inc
View Study Details
RecruitingBeverly Hills, CANCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

178 participants
Boehringer Ingelheim
View Study Details
RecruitingBeverly Hills, CANCT06116916

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME....

150 participants
Kyowa Kirin Co., Ltd.
View Study Details
RecruitingBeverly Hills, CANCT06727552

A Study of Barzolvolimab in Patients With Atopic Dermatitis

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis...

120 participants
Celldex Therapeutics
View Study Details
RecruitingBeverly Hills, CANCT06770933

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Typ...

100 participants
Vantage Biosciences Ltd
View Study Details

About Interstitial Cystitis Clinical Trials in Beverly Hills

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 13 interstitial cystitis clinical trials recruiting participants in Beverly Hills, CA. These studies are seeking a combined 12,793 participants. Research is being sponsored by AstraZeneca, Kardigan, Inc., Hoffmann-La Roche and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Beverly Hills — FAQ

Are there interstitial cystitis clinical trials in Beverly Hills?

Yes, there are 13 interstitial cystitis clinical trials currently recruiting in Beverly Hills, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Beverly Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beverly Hills research site will contact you about next steps.

Are clinical trials in Beverly Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beverly Hills studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 13 active trials in Beverly Hills are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov